Reposted by @luke-jones.bsky.socialCarroll Lab Oxford @carroll-lab.bsky.social · 22/07/2025Our lab is attending the UK-ICN (uk-icn.co.uk) AGM this week - look out for out talks! Developing nanobodies as pan-SARS-CoV-2 therapeutics by Luke Jones, today (22/7) at 14:00 High prevalence of sarbecovirus in a single bat roost in Gloucestershire, UK by Dung Nguyen - thursday 24/7 at 9:45 041
luke-jones.bsky.social @luke-jones.bsky.social · 03/04/2025Delighted to present my work on SARS-CoV-2 neutralising nanobodies at #MicroBio25 this year. 051
Reposted by @luke-jones.bsky.socialDaniel MacPhee 🇨🇦 @d-macphee.bsky.social · 02/04/2025“Although it is still unclear precisely how herpes zoster vaccination lowers the risk of dementia, the implications of the study are profound.The vaccine could represent a cost-effective intervention that has public-health benefits” #Dementia #Shingles #Vaccination 🧪 www.nature.com/articles/d41...nature.comCould the shingles vaccine help to prevent dementia?Large-scale analyses of electronic health data suggest that the herpes zoster vaccine could protect against dementia — but it’s not yet clear how. 67021